-
Collagen Scaffold for Cartilage Repair approved for marketing
2023-04-04
Recently, the innovative product Collagen Scaffold for Cartilage Repair (COLTRIX CartiRegen) of Ubiosis Co., Ltd is approved by China NMPA.
-
Management of COVID-19 insurance reimbursement to be downgraded
2023-04-04
China will downgrade its COVID-19 insurance reimbursement management level to a Class B infectious disease in line with its management of the disease starting Saturday, a new notice said on Thursday.
-
New oral antiviral drug to be used for treatment of COVID-19
2023-03-27
The National Medical Products Administration has recently granted conditional market approval for an oral antiviral drug RAY1216 in a bid to treat COVID-19.
-
Third domestically developed ECMO machine receives approval
2023-02-24
The National Medical Products Administration said on Thursday it has granted emergency authorization to the third homegrown extracorporeal membrane oxygenation machine.
-
Spread of COVID-19 epidemic in China basically ended, expert says
2023-02-24
The spread of the COVID-19 epidemic has basically ended in China, though it is not completely over, a senior health expert said on Thursday.
-
China steadily enters new phase of COVID response: spokesperson
2023-02-24
China has steadily entered a new phase of COVID-19 prevention and control, which was downgraded under the management of Class B infectious diseases, a National Health Commission spokesperson said Thursday.
